참고문헌
- Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735. https://doi.org/10.1016/S0735-1097(03)00787-3
- Song BG, Jeon ES, Kim YH, et al. Correlation between levels of Nterminal pro-B-type natriuretic peptide and degrees of heart failure. Korean J Intern Med 2005;20:26-32. https://doi.org/10.3346/jkms.2005.20.1.26
- Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174. https://doi.org/10.1161/01.CIR.0000144310.04433.BE
- Gardner RS, Ozalp F, Murday AJ, et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743. https://doi.org/10.1016/j.ehj.2003.07.005
- Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1995;141:637-644.
- Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971- 1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-2410. https://doi.org/10.1001/jama.283.18.2404
- Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-1551. https://doi.org/10.1001/archinte.164.14.1546
- Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 2000;36:1072-1078. https://doi.org/10.1161/01.HYP.36.6.1072
- Mazza A, Pessina AC, Pavei A, et al. Predictors of stroke mortality in elderly people from the general population: the cardiovascular study in the elderly. Eur J Epidemiol 2001;17:1097-1104. https://doi.org/10.1023/A:1021216713504
- Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003;34:1951-1956. https://doi.org/10.1161/01.STR.0000081983.34771.D2
- Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-1507. https://doi.org/10.1161/01.STR.0000221716.55088.d4
- Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-1997. https://doi.org/10.1161/01.CIR.0000065637.10517.A0
- Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. https://doi.org/10.1093/eurheartj/ehi044
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41. https://doi.org/10.1159/000180580
- Leyva F, Chua TP, Anker SD, et al. Uric acid in chronic heart failure: a measure of the anaerobic threshold. Metabolism 1998;47:1156-1159. https://doi.org/10.1016/S0026-0495(98)90293-1
- Leyva F, Anker S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-865. https://doi.org/10.1093/oxfordjournals.eurheartj.a015352
- Doehner W, von Haehling S, Anker SD. Uric acid as a prognostic marker in acute heart failure: new expectations from an old molecule. Eur J Heart Fail 2007;9:437-439. https://doi.org/10.1016/j.ejheart.2007.03.006
- Sakai H, Tsutamoto T, Tsutsui T, et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J 2006;70:1006-1011. https://doi.org/10.1253/circj.70.1006
- Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-2411. https://doi.org/10.1161/hc4501.098928
- Cingolani HE, Plastino JA, Escudero EM, et al. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study. J Card Fail 2006;12:491-498. https://doi.org/10.1016/j.cardfail.2006.05.005
- Struthers AD, Donnan PT, Lindsay P, et al. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-234. https://doi.org/10.1136/heart.87.3.229
- Pascual-Figal DA, Hurtado-Martínez JA, Redondo B, et al. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail 2007;9:518-524. https://doi.org/10.1016/j.ejheart.2006.09.001
- Landmesser U, Spiekermann S, Dikalov S, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002;106:3073-3078. https://doi.org/10.1161/01.CIR.0000041431.57222.AF
- Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283. https://doi.org/10.1161/01.CIR.0000054164.99881.00
- Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587-1593. https://doi.org/10.1016/S0735-1097(00)00912-8
- Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006;47:91-97. https://doi.org/10.1016/j.jacc.2005.08.051
피인용 문헌
- Upstream therapies after pulmonary vein ablation: five negative studies--what's next? vol.12, pp.11, 2010, https://doi.org/10.1093/europace/euq402
- The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitu vol.14, pp.3, 2010, https://doi.org/10.14341/2072-0351-6221
- Prognostic markers for acute heart failure vol.7, pp.4, 2010, https://doi.org/10.1517/17530059.2013.814638
- Comparison of Prognostic Value of Red Cell Distribution Width and NT-proBNP for Short-Term Clinical Outcomes in Acute Heart Failure Patients vol.55, pp.1, 2010, https://doi.org/10.1536/ihj.13-172
- BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review vol.19, pp.4, 2010, https://doi.org/10.1007/s10741-014-9442-y
- Liver Enzymes and Uric acid in Acute Heart Failure vol.4, pp.4, 2010, https://doi.org/10.5812/cardiovascmed.4(2)2015.22988
- Prognostic value of serum uric acid in patients with acute heart failure : A meta-analysis vol.98, pp.8, 2010, https://doi.org/10.1097/md.0000000000014525
- Prognostic value of prealbumin, N-terminal pro-B-type natriuretic peptide, heart type fatty acid binding protein, and cardiac troponin I in elderly patients for heart failure and poor outcomes vol.49, pp.5, 2010, https://doi.org/10.1177/0300060521999742